IC
LAB icon

IEQ Capital’s Standard BioTools LAB Stock Holding History

IEQ Capital’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$109K Buy
118,550
+79,995
+207% +$96.8K ﹤0.01% 1787
2025
Q4 		$49.4K Sell
38,555
-7,989
-17% -$10.7K ﹤0.01% 1805
2025
Q3 		$60.5K Buy
46,544
+630
+1% +$825 ﹤0.01% 1788
2025
Q2 		$55.1K Sell
45,914
-17,268
-27% -$19.1K ﹤0.01% 1758
2025
Q1 		$68.2K Buy
+63,182
New +$88.7K ﹤0.01% 1528

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

IEQ Capital's LAB Position: Q1 2026 in Review

IEQ Capital increased its Standard BioTools (LAB) stake by 207% in Q1 2026, buying an estimated $96.8K and bringing the position to 118,550 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

IEQ Capital first reported a position in LAB in Q1 2025 and has held it in 5 quarters since. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • IEQ Capital held 118,550 shares of Standard BioTools worth $109K as of Q1 2026.
  • IEQ Capital bought 79,995 Standard BioTools shares in Q1 2026, an estimated $96.8K.
  • Standard BioTools made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1787 holding.
  • IEQ Capital first reported a position in Standard BioTools in Q1 2025 and has held it in 5 quarters since.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.